by Jordana Choucair | Aug 19, 2022 | Opioid/Substance Use Disorders
Tipping the Pain Scale – a documentary film that tells the story of the opioid epidemic, produced by Third Horizon Strategies Managing Director Greg Williams – will be available via Apple TV on September 6. The film captures the perspectives of individuals who are...
by Jordana Choucair | Aug 18, 2022 | Access & Coverage
The Centers for Medicare & Medicaid Services (CMS) approved the extension of Medicaid and Children’s Health Insurance Program (CHIP) coverage for 12 months after pregnancy in Hawaii, Maryland, and Ohio. The approvals will give an estimated 34,000 people a full...
by Jordana Choucair | Aug 18, 2022 | Life Sciences
The Food and Drug Administration (FDA) approved Bluebird Bio Inc.’s Zynteglo gene therapy. The approval gives patients suffering from a rare genetic blood disorder called beta-thalassemia a possible cure, at a hefty price. Bluebird, which has priced the...
by Jordana Choucair | Aug 18, 2022 | Opioid/Substance Use Disorders
A federal judge yesterday ordered CVS, Walgreens, and Walmart to pay $650 million to two Ohio counties, claiming the way they distributed opioids caused severe harm and created a public nuisance. The judge’s verdict is the first federal ruling to put a price tag on...
by Jordana Choucair | Aug 18, 2022 | Opioid/Substance Use Disorders
The Wisconsin Legislature’s Joint Committee on Finance rejected Governor Tony Evers’ spending plan for $31 million in settlement funds to combat the state’s opioid epidemic. The plan proposed using the money to increase the availability of NARCAN, invest in new...
by Jordana Choucair | Aug 18, 2022 | Payers
J.D. Power’s annual study of Medicare Advantage (MA) plans found that members are satisfied with the plans, but say mental health and substance use disorder (SUD) treatment coverage is lacking. Ninety-one percent members said they have enough coverage for...
Recent Comments